Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy

BACKGROUND: The purpose of this study was to evaluate nepafenac ophthalmic suspension 0.1% (Nevanac(®); Alcon Research Ltd) in the prevention of macular edema following cataract surgery in diabetic retinopathy patients. METHODS: This was a multicenter, randomized, double-masked, vehicle-controlled s...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Rishi, Alpern, Louis, Jaffe, Glenn J, Lehmann, Robert P, Lim, John, Reiser, Harvey J, Sall, Kenneth, Walters, Thomas, Sager, Dana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422154/
https://www.ncbi.nlm.nih.gov/pubmed/22927737
http://dx.doi.org/10.2147/OPTH.S31902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422154/
https://www.ncbi.nlm.nih.gov/pubmed/22927737
http://dx.doi.org/10.2147/OPTH.S31902

Ejemplares similares